Baxter signs British flu vaccine deal

Aug 17, 2007

Baxter International said it has entered into an agreement to supply Britain with flu vaccine in the event of a bird flu pandemic.

The Deerfield, Ill., company is in the final stages of testing for a vaccine against H5N1 strains of avian influenza.

Baxter said it will manufacture its pandemic vaccine in a serum-free, vero cell-based system that accelerates vaccine availability. The company said vaccines produced using this process can be released within approximately 12 weeks, significantly earlier than with traditional egg-based systems.

The vero cell culture gives the company the flexibility to quickly respond to emerging variant pandemic virus strains, Baxter said in a news release.

The Chicago Tribune said the advanced supply agreement could be worth tens of millions of dollars to the company over the next four years.

British health officials said they signed more than $300 million in contracts with Baxter and GlaxoSmithKline to supply a vaccine as soon as the strain is identified by the World Health Organization.

Copyright 2007 by United Press International

Explore further: FDA approves second vaccine against meningitis strain

add to favorites email to friend print save as pdf

Related Stories

Davos elites warned about catastrophic cyberattacks

18 hours ago

Attacks on power plants, telecommunications and financial systems, even turning all of Los Angeles' traffic lights green: Davos elites were warned Saturday of the terrifying possibilities of modern cyber ...

Recommended for you

Generic form of nexium approved

9 hours ago

(HealthDay)—The first generic version of the heartburn drug Nexium (esomeprazole) has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.